Skip to content

Organon OGN Common Stock

Common Stock at other companies

Amgen logo
AmgenAMGN
2.8B0.0%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
480M0.0%
Biogen logo
BiogenBIIB
$100K0.0%
AbbVie logo
AbbVieABBV
$18M0.0%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$10
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
500M0.0%

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's common stock?
Organon (OGN) reported common stock of 500M in Q1 2026.
How has Organon's common stock changed year-over-year?
Organon's common stock decreased by 0.0% year-over-year, from 500M to 500M.
What is the long-term trend for Organon's common stock?
Over 4 years (2021 to 2025), Organon's common stock has grown at a 259.3% compound annual growth rate (CAGR), from 3M to 500M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).